SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syncom Formulations India informs about company updates

24 Nov 2015 Evaluate

Syncom Formulations India has informed that In compliance of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015 the Company has submitted a copy of Policy for Determination of Materiality under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015. Further note that the above said policy was approved by the Board of Directors at their meeting held on November 07, 2015 and shall become applicable with effect from December 01, 2015.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

14.18 0.17 (1.21%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: